|
CN101766593A
|
|
Medical composition containing amorphous atorvastatin calcium
|
|
CN101769904A
|
|
Method utilizing HPLC (high performance liquid chromatography) to measure oxalate escitalopram optical isomer
|
|
CN101768136A
|
|
New crystal form of febuxostat and preparation method thereof
|
|
CN101768197A
|
|
Preparation method for nelarabine
|
|
CN101769902A
|
|
Method for analyzing and separating optical isomer of pramipexole dihydrochloride by using HPLC method
|
|
CN101769905A
|
|
Method utilizing HPLC (high performance liquid chromatography) to measure eplerenone cis-trans isomer
|
|
CN101762650A
|
|
Method for determining related substances of naratriptan hydrochloride by high performance liquid chromatography
|
|
CN101757639A
|
|
Formulation of huperzine A and beta-cyclodextrin composition
|
|
CN101762648A
|
|
Method for determining related substances of felodipine sustained-release tablets by using HPLC
|
|
CN101676272A
|
|
preparation method of pramipexole
|
|
CN101676283A
|
|
preparation method of naratriptan
|
|
CN101609071A
|
|
A kind of HPLC method analysis separates the method for ivabradine hydrochloride intermediate optical isomer
|
|
CN101609069A
|
|
A kind of method of measuring Entecavir and Pharmaceutical composition related substance thereof with the HPLC method
|
|
CN101606937A
|
|
Solid composite medicament of a kind of lomerizine and preparation method thereof
|
|
CN101609076A
|
|
A kind of method that detects Clinofibrate and intermediate thereof with vapor-phase chromatography
|
|
CN101606926A
|
|
A kind of pharmaceutical composition that contains dopexamine hydrochloride
|
|
CN101609070A
|
|
A kind of method of measuring related substances of losastan potassium/hydrochlorothiazide tablets with HPLC
|
|
CN101606935A
|
|
A kind of solid composite medicament that contains clopidogrel
|
|
CN101548943A
|
|
Inhalation nebulizer containing formoterol
|
|
CN101548942A
|
|
Oral solid pharmaceutical composition containing clinofibrate
|
